4.6 Article

Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients

Journal

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 147, Issue 9, Pages 2741-2750

Publisher

SPRINGER
DOI: 10.1007/s00432-021-03531-8

Keywords

Squamous cell carcinoma of head and neck; Biomarkers; Programmed death-ligand; Poliovirus receptor

Categories

Funding

  1. National Research Foundation of Korea (NRF) - Korean Government (MSIT) [NRF-2017M3A9E9072669, 2017M3A9E8029717, NRF2019M3A9B6065231(sc), 2018R1A2A1A05076997, 2017R1A5A1014560]
  2. National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [HA16C0015, HA16C0015020019]
  3. Korea Health Promotion Institute [HA16C0015020019] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  4. National Research Foundation of Korea [2017M3A9E8029717] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

PVR overexpression is a poor prognostic factor in patients with HNSCC, while co-targeting PVR and PD-L1 may be a promising therapeutic option that needs further investigation.
Purpose We aimed to investigate the prognostic value of multiple immune cell markers including programmed death-ligand 1 (PD-L1) and poliovirus receptor (PVR) in head and neck squamous cell carcinoma (HNSCC) using archival tumor tissues Methods Patients diagnosed with HNSCC who have undergone surgical resection in 2005-2012 were included. Correlations between PVR and PD-L1 expression and patient characteristics were analyzed by analysis of variance. The Kaplan-Meier method and log-rank test were used to estimate survival. P values < 0.05 were considered statistically significant. Results In total, 375 primary tumor tissues were analyzed using immunohistochemistry. High PVR expression was associated with a poor prognosis in terms of overall survival (OS) and recurrence-free survival (RFS), and tumors with high PVR expression were associated with a short OS. PD-L1 tumor expression did not have a prognostic impact on survival. Univariate analysis revealed that OS and RFS were affected by age and p16 and PVR expression; multivariate analysis revealed that age and p16 and PVR expression were the most important determinants of RFS. Conclusion PVR overexpression is a poor prognostic factor in patients with HNSCC and co-targeting PVR and PD-L1 may be a promising therapeutic option that needs further investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available